Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Nephrology

Renal Failure Clinical Trials

A listing of Renal Failure medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Phoenix Arizona 85012

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Tucson Arizona 85745

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

California

University of California, San Francisco
San Francisco California 94143

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

Fresno California 93710

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Irvine California 92868

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Long Beach California 90822

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Mather California 95655

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

San Diego California 92123

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Connecticut

West Haven Connecticut 06516

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Florida

Tampa Florida 33606

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Illinois

Alsip Illinois 60803

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Maryland

University of Maryland School of Medicine
Baltimore Maryland 21201

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

Easton Maryland 21601

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Massachusetts

Massachussetts General Hospital
Boston Massachusetts 02114

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

Boston Massachusetts 02115

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Boston Massachusetts 02114

A Phase 4 clinical study for patients with Renal Failure

Michigan

Flint Michigan 48507

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Mississippi

Greenwood Mississippi 38930

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Missouri

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

New Jersey

Newark New Jersey 07103

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Westfield New Jersey 07090

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

New York

The Rogosin Institute - New York Presbyterian
New York New York 10021

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

North Carolina

Durham North Carolina 27710

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Oregon

Portland Oregon 97201

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Pennsylvania

University of Pennsylvania
Philadelphia Pennsylvania 19104

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

Hershey Pennsylvania 17033

A clinical trial for patients with Immunosuppression or Renal Failure

South Carolina

Orangeburg South Carolina 29118

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Texas

Dallas Texas 75226

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Wisconsin

University of Wisconsin
Madison Wisconsin 53792

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

Madison Wisconsin 53706

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Madison Wisconsin 53792

Patients are needed to participate in a clinical research study evaluating 62Cu-ethylglyoxal bis(thiosemicarbazone), 15O-water and Positron Emission Tomography for the treatment of Renal Failure or Renal Artery Stenosis

Germany

Berlin 13353

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Darmstadt Hessen 64283

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Erlangen Bayern 91054

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Frankfurt/Main Hessen 60590

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Israel

Hadera Haifa 38100

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Haifa 3109601

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Jerusalem 9103102

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Ramat Gan Tel-Aviv 52621

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Tzrifin 70300

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Japan

Iizuka Fukuoka 820-8505

A clinical research study of Revlimid for the treatment of Lymphoma

Poland

Lublin Lubelskie 20-081

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Poznan 61-848

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Warszawa 02-097

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Wroclaw 51-124

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Portugal

Porto 4250-449

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Switzerland

Biel/Bienne 2501

A clinical trial to evaluate treatments for patients with Hypoosmolality, Hyperosmolality or Renal Failure

Taiwan

Kaohsiung 83301

A Phase 4 clinical study for patients with Kidney Failure, Chronic, End-stage Renal Disease, Phosphorus Metabolism Disorders or Hyperphosphatemia

Kaohsiung 80756

A Phase 4 clinical study for patients with Kidney Failure, Chronic, End-stage Renal Disease, Phosphorus Metabolism Disorders or Hyperphosphatemia

Keelung 20401

A Phase 4 clinical study for patients with Kidney Failure, Chronic, End-stage Renal Disease, Phosphorus Metabolism Disorders or Hyperphosphatemia